Skip to main content
Quratis Inc. logo

Quratis Inc. — Investor Relations & Filings

Ticker · 348080 ISIN · KR7348080003 KO Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2026-02-12 Capital/Financing Update
Country KR South Korea
Listing KO 348080

About Quratis Inc.

https://www.quratis.com

Quratis Inc. is a biopharmaceutical company specializing in the research and development of vaccines and therapeutic agents for infectious diseases. The company's lead pipeline candidate is QTP101, a novel tuberculosis (TB) vaccine developed for adolescents and adults, an area with significant unmet medical needs. Quratis operates its own GMP-certified manufacturing facility, enabling the production of various biologics such as DNA plasmids, RNA, and proteins to support its development programs. The company is advancing the global commercialization of its TB vaccine through strategic partnerships and technology transfers, with notable progress in key Asian markets.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채매수선택권행사자지정)
Capital/Financing Update Classification · 95% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service in South Korea. It specifically details the designation of a party to exercise a call option (매수선택권) on convertible bonds (전환사채). This type of filing relates to the company's capital structure and financing arrangements, specifically the management of convertible debt instruments. According to the provided definitions, this falls under 'Capital/Financing Update' (CAP) as it concerns the exercise of call options on debt securities.
2026-02-12 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Quratis) regarding a 'Single Sale/Supply Contract' amendment. It details the termination of a contract and provides updated financial information related to that specific contract. Since it is a formal regulatory announcement regarding a business contract update and does not fit into specific categories like M&A or financial reports, it is classified as a general regulatory filing.
2026-01-23 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Quratis) regarding a 'Single Sale/Supply Contract' amendment. It details a change in the contract end date and provides specific financial terms of the supply agreement. Since this is a formal regulatory disclosure of a material business contract update, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, Dividends, or Share Repurchases.
2025-12-30 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (Quratis) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). This is a standard material event disclosure required by the Korea Exchange (KRX) for significant contracts. Since it does not fit into specific categories like M&A, dividends, or share repurchases, it falls under the general regulatory filing category.
2025-12-24 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the amendment of a previously announced convertible bond issuance (전환사채권 발행결정 정정신고). It details specific changes to conversion periods, call/put option terms, and adjustments to the conversion price. Since this is a formal regulatory filing detailing changes to capital structure and financing terms, it falls under the 'Capital/Financing Update' category.
2025-12-18 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding Status (Abbreviated)'. It details changes in shareholding percentages, number of shares held, and related information about a major shareholder, including specifics about conversion of convertible bonds to shares and changes in investment purpose. The document references legal provisions related to reporting large shareholdings and is focused on notifying regulatory bodies and the stock exchange about significant share ownership changes. There is no indication of financial statements, earnings data, management commentary, or other report types. This matches the definition of a Major Shareholding Notification (MRQ), which is a notification of changes in significant share ownership levels crossing thresholds.
2025-11-05 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.